在接受ECMO支持的患者中激活凝血时间和静血并发症:系统性审查
Daniel Schwaiger1, Lukas Schausberger1, Benedikt Treml1
1Department of Anaesthesiology and Intensive Care, Medical University of Innsbruck, Anichstraße. 35, 6020 Innsbruck, Austria.
Journal of cardiovascular development and disease
|July 25, 2025
概括
在用未分离的肝素 (UFH) 进行体外膜氧化 (ECMO) 期间,激活凝血时间 (ACT) 监测没有显示出与出血或血栓形成有显著联系. 目前的证据表明,ACT对ECMO抗凝管理可能不可靠.
科学领域:
- 关键护理医学 关键护理医学
- 心血管外科心血管外科
- 血液学 血液学 血液学
背景情况:
- 身体外膜氧化 (ECMO) 需要全身抗凝剂,通常是未分离的肝素 (UFH),以防止电路血栓形成.
- 使用UFH的抗凝固药物具有固有的出血风险,需要谨慎监测.
- 激活凝血时间 (ACT) 经常用于监测UFH抗凝,但其在ECMO患者中的有效性仍在争论中.
研究的目的:
- 在接受ECMO的患者中,系统地审查现有证据,以了解ACT监测与血液静止并发症 (出血和血栓形成) 之间的关联.
- 在ECMO的背景下,评估ACT作为UFH抗凝药的监测工具的可靠性.
主要方法:
- 使用Scopus和PubMed数据库进行了系统的文献审查.
- 研究包括接受ECMO支持的患者,使用UFH抗凝剂,并通过ACT监测.
- 关于出血事件,血栓形成和死亡率的数据被提取和分析.
主要成果:
- 在3536个已识别的出版物中,包括了30项涉及2379名患者的研究.
- 大多数研究 (13/23) 发现ACT值和出血之间没有显著的关联.
- 综合数据显示,大出血率为49%,血栓形成率为25%,住院死亡率为51%.
结论:
- 对ECMO的最佳抗凝血监测策略尚不清楚.
- 目前的证据不支持在ECMO患者的ACT水平和血液静止并发症之间存在显著的关系.
- ACT可能是监测ECMO中UFH抗凝的不可靠工具,需要对替代方法进行调查.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24


